The fairness objection to paying donors—that only rich people would get kidneys and poor people would donate—is misguided: a black market already sends rich patients to unsavory sources (e.g., China, possibly executed prisoners), kidney patients are mostly working and middle class (a third are African-American), and any payment system would operate through the same public/private insurance infrastructure as the rest of the transplant system.